Kuwait Sepsis Diagnostics Market Size & Outlook, 2022-2030

The sepsis diagnostics market in Kuwait is expected to reach a projected revenue of US$ 5.2 million by 2030. A compound annual growth rate of 7.6% is expected of Kuwait sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$2.9
Forecast, 2030 (US$M)
$5.2
CAGR, 2023 - 2030
7.6%
Report Coverage
Kuwait

Kuwait sepsis diagnostics market highlights

  • The Kuwait sepsis diagnostics market generated a revenue of USD 2.9 million in 2022 and is expected to reach USD 5.2 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 2.9 million
Market revenue in 2030USD 5.2 million
Growth rate7.6% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.3% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.5 million by 2030.

Blood culture media was the largest segment with a revenue share of 37.93% in 2022. Horizon Databook has segmented the Kuwait sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


In Kuwait, diagnosing sepsis involves a combination of clinical examination, laboratory tests, and imaging studies. Blood cultures are crucial in identifying the infectious agent responsible for sepsis and septic shock.  Additional laboratory tests, including a complete blood count, kidney function tests, and inflammatory markers, are used to diagnose sepsis and gauge its severity.

Imaging techniques such as chest X-ray, ultrasound, or CT scans help locate the infection source or assess organ dysfunction. Once sepsis or septic shock is diagnosed, treatment with antibiotics, fluid resuscitation, and supportive care are promptly initiated to enhance patient recovery.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Kuwait sepsis diagnostics market size, by product, 2018-2030 (US$M)

Kuwait Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Kuwait sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more